Considering the above-mentioned roles of PPAR-α and PPAR-γ, they may be the underlying target genes that are induced in the PSE-mediated attenuation of the progression of NAFLD. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.